Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 266

1.

Consequences of beta-glucocerebrosidase deficiency in epidermis. Ultrastructure and permeability barrier alterations in Gaucher disease.

Holleran WM, Ginns EI, Menon GK, Grundmann JU, Fartasch M, McKinney CE, Elias PM, Sidransky E.

J Clin Invest. 1994 Apr;93(4):1756-64.

2.

Processing of epidermal glucosylceramides is required for optimal mammalian cutaneous permeability barrier function.

Holleran WM, Takagi Y, Menon GK, Legler G, Feingold KR, Elias PM.

J Clin Invest. 1993 Apr;91(4):1656-64.

3.

Permeability barrier requirements regulate epidermal beta-glucocerebrosidase.

Holleran WM, Takagi Y, Menon GK, Jackson SM, Lee JM, Feingold KR, Elias PM.

J Lipid Res. 1994 May;35(5):905-12.

4.

Epidermal abnormalities may distinguish type 2 from type 1 and type 3 of Gaucher disease.

Sidransky E, Fartasch M, Lee RE, Metlay LA, Abella S, Zimran A, Gao W, Elias PM, Ginns EI, Holleran WM.

Pediatr Res. 1996 Jan;39(1):134-41.

PMID:
8825398
5.

Glucosylceramide metabolism is regulated during normal and hormonally stimulated epidermal barrier development in the rat.

Hanley K, Jiang Y, Holleran WM, Elias PM, Williams ML, Feingold KR.

J Lipid Res. 1997 Mar;38(3):576-84.

6.
7.

beta-Glucocerebrosidase activity in murine epidermis: characterization and localization in relation to differentiation.

Holleran WM, Takagi Y, Imokawa G, Jackson S, Lee JM, Elias PM.

J Lipid Res. 1992 Aug;33(8):1201-9.

8.

The aged epidermal permeability barrier. Structural, functional, and lipid biochemical abnormalities in humans and a senescent murine model.

Ghadially R, Brown BE, Sequeira-Martin SM, Feingold KR, Elias PM.

J Clin Invest. 1995 May;95(5):2281-90.

9.

Structural and biochemical basis for the UVB-induced alterations in epidermal barrier function.

Holleran WM, Uchida Y, Halkier-Sorensen L, Haratake A, Hara M, Epstein JH, Elias PM.

Photodermatol Photoimmunol Photomed. 1997 Aug;13(4):117-28.

PMID:
9453079
10.

Sphingolipid activator proteins are required for epidermal permeability barrier formation.

Doering T, Holleran WM, Potratz A, Vielhaber G, Elias PM, Suzuki K, Sandhoff K.

J Biol Chem. 1999 Apr 16;274(16):11038-45.

11.

Epidermal sphingomyelins are precursors for selected stratum corneum ceramides.

Uchida Y, Hara M, Nishio H, Sidransky E, Inoue S, Otsuka F, Suzuki A, Elias PM, Holleran WM, Hamanaka S.

J Lipid Res. 2000 Dec;41(12):2071-82.

12.

Beta-glucocerebrosidase activity in mammalian stratum corneum.

Takagi Y, Kriehuber E, Imokawa G, Elias PM, Holleran WM.

J Lipid Res. 1999 May;40(5):861-9.

13.
14.

Extracellular processing of phospholipids is required for permeability barrier homeostasis.

Mao-Qiang M, Feingold KR, Jain M, Elias PM.

J Lipid Res. 1995 Sep;36(9):1925-35.

15.

Physicochemical analysis of liposome membranes consisting of model lipids in the stratum corneum.

Aburai K, Yoshino S, Sakai K, Sakai H, Abe M, Loiseau N, Holleran W, Uchida Y, Sakamoto K.

J Oleo Sci. 2011;60(4):197-202.

16.

Glucocorticoids accelerate fetal maturation of the epidermal permeability barrier in the rat.

Aszterbaum M, Feingold KR, Menon GK, Williams ML.

J Clin Invest. 1993 Jun;91(6):2703-8.

17.

Ultraviolet B-induced alterations of the skin barrier and epidermal calcium gradient.

Jiang SJ, Chu AW, Lu ZF, Pan MH, Che DF, Zhou XJ.

Exp Dermatol. 2007 Dec;16(12):985-92.

PMID:
18031457
18.
19.

Fatty acids are required for epidermal permeability barrier function.

Mao-Qiang M, Elias PM, Feingold KR.

J Clin Invest. 1993 Aug;92(2):791-8.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk